Knockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma
Cancer Reports · 2026
DOI: 10.1002/cnr2.70683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Runbiao Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Ribosomal Proteins, Biomarkers, Tumor. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peiyu Project of the Meizhou People's Hospital, Medical Science and Technology Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Background
Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive histological subtype of kidney cancer. Previous studies have implicated ribosomal protein L28 (RPL28) in the progression of various cancers; however, its role in ccRCC remains unclear.
Aims
This study aimed to investigate the expression, prognostic significance, and potential biological role of RPL28 in ccRCC. Methods and Results RPL28 expression data and corresponding clinicopathological information were obtained from the UCSC Xena platform, and pan‐cancer expression patterns were assessed using TIMER2.0. RPL28 expression was further validated in clinical ccRCC tissue samples. Prognostic, immune‐infiltration, and drug‐sensitivity analyses were performed, and the biological effects of RPL28 were evaluated using lentivirus‐mediated knockdown in ccRCC cells. RPL28 was significantly upregulated in ccRCC tissues and was associated with unfavorable overall survival (OS) and disease‐specific survival (DSS), as well as adverse clinicopathological features, including higher histological grade, advanced T stage, distant metastasis, and advanced TNM stage. Immune analyses revealed associations between RPL28 expression and selected features of the ccRCC immune microenvironment, while pharmacogenomic analyses suggested potential associations between RPL28 expression and predicted sensitivity to selected targeted agents. In vitro, RPL28 knockdown significantly inhibited ccRCC cell proliferation and migration. Gene set enrichment analysis (GSEA), together with experimental findings, further suggested that RPL28 may be involved in epithelial–mesenchymal transition (EMT)‐related processes in ccRCC.
Conclusion
RPL28 is overexpressed in ccRCC and is associated with poor survival outcomes, malignant cellular phenotypes, EMT‐related signaling, selected immune‐microenvironmental features, and predicted therapeutic‐response phenotypes. These findings suggest that RPL28 may serve as a prognostic biomarker and potential therapeutic target in ccRCC, although further mechanistic and clinical validation is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.
- Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, People's Republic of China.
- Shantou University Medical College, Shantou, People's Republic of China.
- Department of Pathology, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, People's Republic of China.
ORCID-Profile: Runbiao Luo, Zhouzhou Xie, Huiming Jiang
Förderung
- Peiyu Project of the Meizhou People's Hospital
- Medical Science and Technology Research Foundation of Guangdong Province
Zitieren
APA
Luo, R., Wu, G., Xie, Z., Xiao, Y., Zhu, W., & Jiang, H. (2026). Knockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma. Cancer Reports. https://doi.org/10.1002/cnr2.70683
Vancouver
Luo R, Wu G, Xie Z, Xiao Y, Zhu W, Jiang H. Knockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma. Cancer Reports. 2026. doi:10.1002/cnr2.70683
BibTeX
@article{Luo2026,
author = {Luo, Runbiao and Wu, Guozhong and Xie, Zhouzhou and Xiao, Yuchen and Zhu, Wenbiao and Jiang, Huiming},
title = {Knockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma},
journal = {Cancer Reports},
year = {2026},
doi = {10.1002/cnr2.70683}
}
EUVIMED